Lithium can be toxic if not used properly. Further, the research is still in the early stages and it is unlikely that a ...

While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 ...

New research suggests that lithium is depleted in the brains of Alzheimer's patients and is essential for normal brain ...

Early studies suggest that lifestyle changes such as diet, exercise and social engagement may help slow or prevent ...

Ascension became the first provider in Wisconsin to administer Kisunla, a new FDA-approved drug for Alzheimer’s, which is ...

The Alzheimer’s disease market has achieved a groundbreaking milestone with the FDA approval of LEQEMBI IQLIK (lecanemab-irmb ...

Alzheimer’s disease is a progressive neurodegenerative disease that affects an individual’s behavior, memory, and mental capabilities. Alzheimer’s allows for the build-up of proteins in the brain, ...

In 2021, eefit expanded its global collaboration network by partnering with Dr. Neher’s Biophysics Laboratory for Innovative ...

If deep brain stimulation (DBS) can help people with Parkinson’s disease walk and speak again, could it help people with Alzheimer’s disease, too? It’s a natural question, and one that researchers are ...

The combination of a recently approved blood test for detection of Alzheimer's disease combined with two medications that slow progression of the disease is drastically improving outcomes for patients ...

The anti-amyloid maintenance therapy offers a once-weekly, subcutaneous option after 18 months of intravenous treatment.

The Wasatch Back Alzheimer's Association chapter hosted its annual Walk to End Alzheimer’s Saturday, Sept. 6. The group’s ...